Skip to Content

NAT 375 (Armodafinil 250 mg)

Pill with imprint NAT 375 is White, Elliptical / Oval and has been identified as Armodafinil 250 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for NAT 375

Armodafinil 250 mg NAT 375

Armodafinil

Imprint
NAT 375
Strength
250 mg
Color
White
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0324
Inactive Ingredients
lactose anhydrous, croscarmellose sodium, magnesium stearate, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.